Radient Technologies Inc Share Price Toronto S.E.
Equities
CA75034P1062
Pharmaceuticals
Sales 2021 | 24.89L 18.25L 15Cr | Sales 2022 | 36.22L 26.56L 22Cr | Capitalization | 2.92Cr 2.14Cr 178.7Cr |
---|---|---|---|---|---|
Net income 2021 | -4.2Cr -3.08Cr -257.05Cr | Net income 2022 | -1.2Cr -88L -73Cr | EV / Sales 2021 | 21.6 x |
Net Debt 2021 | 1.14Cr 83.9L 70Cr | Net Debt 2022 | 1.37Cr 1Cr 84Cr | EV / Sales 2022 | 11.8 x |
P/E ratio 2021 |
-0.85
x | P/E ratio 2022 |
-1.93
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Splinter
FOU | Founder | - | 12/01/12 |
Director of Finance/CFO | - | 22/14/22 | |
Zachary Riauka
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 22/14/22 | |
Steven Splinter
FOU | Founder | - | 12/01/12 |
Jan Petzel
BRD | Director/Board Member | 51 | 23/16/23 |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 602.09Cr | |
-21.28% | 418.94Cr | |
+4.52% | 325.49Cr | |
-18.16% | 287.36Cr | |
-7.70% | 237.49Cr | |
+41.50% | 188.52Cr | |
-4.05% | 157.98Cr | |
-15.56% | 154.04Cr | |
-14.62% | 150.16Cr |